DEANNA JOHNSON: Open Payments
NPI 1316447881 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 10 payments from 8 companies in 2025. Trend: 2023 $34 · 2024 $159 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| Corcept Therapeutics | 1 | $15 |
Products named: JYNARQUE, Fabhalta, GIVLAARI, Ozempic, ULTOMIRIS, SHINGRIX, FUROSCIX, Korlym.
Industry payments across FL — which companies pay providers there.
